
The 1H surge in counter-cyclicals relative to the overall MSCI Europe index has been somewhat of a pattern over the last few years. Each time, counter-cyclicals have outperformed for the first half of the year and then lagged for the second half. So far this year, the gains have been a bit more muted:

Has enthusiasm for more these more defensive sectors waned somewhat in the face of extended valuations?



Though the familiar early outperformance of counter-cyclicals has been more restrained this year, we wouldn't bet on a rotation into European cyclicals quite yet. Relative momentum in the cyclical groups continues to underwhelm and counter-cyclical performance is still stronger than cyclicals, overall:




